跳转至内容
Merck
CN
HomeWebinarsSynthesis Automation with SYNTHIA® & SynpleChem

Synthesis Automation with SYNTHIA® & SynpleChem



WEBINAR

Despite significant advances in recent decades, synthetic chemistry remains a highly challenging field. Synthesis of novel molecules with unique properties is an essential tool in drug discovery but remains a time-consuming endeavor that can often be a bottleneck to the overall process. With an increasing demand for novel molecules with specific properties, there is a pressing need to streamline the synthesis process. In this webinar discover how automation reduces manual effort in route planning and material sourcing, thereby accelerating the overall drug discovery process.

Key learnings:

  • Gain insights into how SYNTHIA® restrosynthesis software can serve as a powerful tool for tailored retrosynthetic analysis, improving the synthesis of novel molecules.
  • Understand how the Synple automated synthesis platform enables quick execution of planned routes, saving valuable time.
  • Discover how the combined capabilities of SYNTHIA® and SynpleChem create a seamless workflow, enhancing the efficiency and effectiveness of the synthesis process.

Speakers

Emma Gardener

Emma Gardener

Merck

Ph.D. Technical Application Scientist

Emma Gardener received her undergraduate degree from Trinity College and worked for several years as a research associate in the biotechnology industry before completing her Ph.D. in Organic Chemistry at Brown University as an NSF graduate research fellow. She studied under Prof. Jason Sello, where she worked on developing new methodology for the synthesis of antibacterial peptide natural products. In 2018, she joined the Cheminformatics Technologies department of Merck as a Technical Application Scientist and is responsible for the commercial licensing of the retrosynthetic design software, SYNTHIA®.

Benedikt Wanner

Benedikt Wanner

SynpleChem

CEO

Benedikt Wanner obtained his PhD in the laboratory of Professor Bode at ETH, where he initiated the Synple platform work. He later established Synple Chem as an automated synthesis company and currently serves as its CEO.



登录以继续。

如要继续阅读,请登录或创建帐户。

暂无帐户?